4//SEC Filing
Conatus Pharmaceuticals Inc. 4
Accession 0001209191-16-112277
CIK 0001383701operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:26 PM ET
Size
5.8 KB
Accession
0001209191-16-112277
Insider Transaction Report
Form 4
Smith Edward F III
SVP, Reg Affairs and QA
Transactions
- Award
Stock Option (Right to Buy)
2016-04-01+100,000→ 100,000 totalExercise: $2.53Exp: 2026-03-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 1, 2016. Twenty-five percent (25%) of the total number of shares of common stock subject to the option will vest on April 1, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:26 PM ET
- Size
- 5.8 KB